SUVEN PHARMACEUTICALS LIMITED revenue for the last year amounted to 10.34 B INR, the most of which — 10.51 B INR — came from its highest performing source at the moment, Manufacturing (CRAMS), the year earlier bringing 13.40 B INR. The greatest contribution to the revenue figure was made by Europe — last year it brought SUVEN PHARMACEUTICALS LIMITED 7.36 B INR, and the year before that — 11.62 B INR.